Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity

International Journal of Oncology

Volumn 28, Issue 6, 2006, Pages 1481-1489

  Kei, Naito ^a   Ueda, Yuji ^a   Itoh, Tsuyoshi ^a   Fuji, Nobuaki ^a   Shimizu, Keiji ^a   Yano, Yutaro ^a   Yamamoto, Yoshiki ^a   Imura, Kenichiro ^a   Kohara, Junji ^a   Iwamoto, Arihiro ^a   Shiozaki, Atsushi ^a   Tamai, Hidemasa ^a   Shimizu, Takeshi ^a   Mazda, Osam ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cancer vaccine therapy; Dendritic cell; Granulocyte macrophage colony stimulating factor; OK 432

Indexed keywords

INTERLEUKIN 4; PICIBANIL;

ANTIGEN PRESENTING CELL; ARTICLE; CULTURE TECHNIQUE; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; METASTASIS; METHODOLOGY; MIXED LYMPHOCYTE CULTURE; MONOCYTE; PATHOLOGY;

ANTIGEN-PRESENTING CELLS; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-4; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; NEOPLASM METASTASIS; PICIBANIL;

EID: 33747149328     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Steinman RM: The dendritic systems and its role in immunogenecity. Annu Rev Immunol 9: 271-296, 1991.
2. Nestle FO, Bachereau J and Hart D: Dendritic cells: on the move from bench to bedside. Nat Med 7: 761-765, 2001.
3. Caux C, Dezutter-Dambuyant C, Schmitt D and Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langhans cells. Nature 360: 258-261, 1992.
4. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 55: 1099-1104, 1995.
5. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182: 1111-1119, 1995.
6. + hematopoietic progenitor cells in cancer patients. Eur J Immunol 26: 595-600, 1996.
7. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 185: 341-350, 1997.
8. + peripheral blood progenitor cells in serum-free medium. Blood 90: 478a, 1997.
9. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179: 1109-1118, 1994.
10. Brossart P, Grunebach F, Stuhler G, Reichardt VL, Mohle R, Kanz L and Brruger W: Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 92: 4238-4247, 1998.
11. Ebner S, Hofer S, Nguyen VA, Nussbaumer W, Romani N and Heufler C: A novel role for IL-3: human monocyte cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward Th2 cytokine pattern. J Immunol 168: 6199-6207, 2002.
12. Davis I, Jefford M, Parente P and Cebon J: Rational approaches to human cancer immunotherapy. J Leukoc Biol 73: 3-29, 2003.
13. Jonuleit H, Giesecke-Tuettenberg A, Tuting T, Thurner-Schuler B, Stuge TB, Paragnik L, Kandemir A, Lee PP, Schuler G, Knop J and Enk AH: A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 93: 243-251, 2001.
14. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
15. + dendritic cells. Proc Natl Acad Sci USA 93: 2588-2592, 1996.
16. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D and Schuler G: Generation of mature dendritic cells from human blood an improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151, 1996.
17. Bender A, Sapp M, Shuler G, Steinman RM and Bhardwaj N: Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J Immunol Methods 196: 121-135, 1996.
18. Jonunulet H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J and Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3147, 1997.
19. Banchereau J and Palucka K: Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296-306, 2005.
20. Itoh T, Ueda Y, Okugawa K, Fujiwara H, Fuji N, Yamashita T, Fujiki H, Harada S, Yoshimura T and Yamagishi H: Streptococcal preparation OK-432 promotes functional maturation of human monocyte-derived dendritic cells. Cancer Immunol Immunother 52: 207-214, 2003.
21. Sakamoto J, Teramukai S, Nakazato H, Sato Y, Uchino J, Taguchi T, Ryoma Y and Ohashi Y: Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. J Immunother 25: 405-412, 2002.
22. Yamaguchi Y, Ohshita A, Kawabuchi Y, Ota K, Shimizu K, Minami K, Hihara J, Miyahara E and Toge T: Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: treatment of Th1 dysfunction in the ascites microenvironment. Int J Oncol 24: 959-966, 2004.
23. Fujimoto T, Duda RB, Szilavasi A, Chen X, Mari M and O'Donnell MA: Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 158: 5619-5626, 1997.
24. Fukui H, Koshihara Y, Nagamuta M, Mizutani Y and Uchida A: Production of interleukin-6 by human spleen cells stimulated with streptococcal preparation OK-432. Immunol Lett 21: 127-130, 1989.
25. Ichimura O, Suzuki S, Saito M, Sugawara Y and Ishida Y: Augmentation of interleukin-1 and interleukin-2 production by OK-432. Int J Immunopharmacol 7: 263-270, 1985.
26. Misaki T, Watanabe Y, Iida Y, Hidaka A, Kasagi K, Fukushima H and Konishi J: Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy. Cancer Immunol Immunother 35: 92-96, 1992.
27. Oshimi K, Kano S, Takaku F and Okumura K: Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J Natl Cancer Inst 65: 1265-1269, 1980. (Pubitemid 11196015)
28. Saito M, Ebina T, Koi M, Yamaguchi T, Kawabe Y and Ishida N: Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell Immunol 68: 187-192, 1982.
29. Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naito K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K and Yamagishi H: Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Int J Oncol 24: 909-917, 2004.
30. Kuroki H, Morisaki T, Matsumoto K, Onishi H, Baba E, Tanaka M and Katano M: Streptcoccal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 52: 561-568, 2003.
31. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F and Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869, 2001.
32. Lu J and Celis E: Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen. Cancer Res 62: 5807-5812, 2002.
33. Ruppert J, Friedrichs D, Xu H and Peters JH: IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 182: 449-464, 1991.
34. Velde AAT, Klomp JPG, Yard BA, De Vries JE and Figdor CG: Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immumol 140: 1548-1554, 1988.
35. Dranoff G, Crawford AD and Sadelain M: Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716, 1994.
36. Metcalf D, Shortman K, Vremec D, Migsud S and Di-Rago L: Effect of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/macs 41 double transgenic mice. Leukemia 10: 713-719, 1996.
37. Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S and Sato M: Expression of Toll-like receptor 4 on dendritic cells is significant for anticancer effect on dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Cancer Res 64: 5461-5470, 2004.
38. Nakahara S, Tsunoda T, Baba T, Asabe S and Tahara H: Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide. Cancer Res 63: 4112-4118, 2003.
39. Feili-Hariri M, Falkner DH and Morel PA: Polarization of naïve T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol 78: 1-9, 2005.